FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40851211000001104: Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Aug 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2373971000001112 Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2373981000001114 Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Is a Noradrenaline (base) 8mg/8ml solution for infusion ampoules true Inferred relationship Existential restriction modifier
Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Norepinephrine true Inferred relationship Existential restriction modifier
Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Has specific active ingredient Norepinephrine bitartrate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) 10 ampoule Has AMP True Noradrenaline (base) 8mg/8ml concentrate for solution for infusion ampoules (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start